Skip to main content
Peptide compounds discussed on this site are for educational and research purposes. Always consult a qualified specialist before use.
Reference BPC-157 5mg FOR RESEARCH
Phase II Evidence Stage
Recovery Primary Domain
Subcutaneous injection Routes Studied
120+ PubMed Citations
Recovery Peptide
Preclinical-Promising

BPC-157

Synthetic peptide studied in animal and cell models for tissue healing and gastric cytoprotection

Last updated: March 1, 2026

Compound Data Sheet
Peer-reviewed References
Evidence Graded
Independent Editorial
Compound
BPC-157
Class
Recovery peptide
Summary
Synthetic peptide studied in animal and cell models for tissue healing, gastric cytoprotection, anti-inflammatory action.
Mechanism
Growth Factor Receptor Upregulation
Research Status
Phase II
Routes Studied
Subcutaneous injection
Evidence Level
Preclinical-promising · Clinically unproven
[ QUICK.ANSWERS ]

What Should You Know About BPC-157?

What is BPC-157?
BPC-157 is a synthetic peptide studied in animal and cell models for tissue healing and gastric cytoprotection.
Is BPC-157 clinically proven?
No. Human evidence remains limited and does not establish BPC-157 as clinically proven. See the full evidence review for a study-by-study breakdown.
What has BPC-157 been studied for?
BPC-157 has been studied in preclinical models of tissue healing, gastric cytoprotection, anti-inflammatory action. These findings have not been confirmed in large-scale human trials.
Is BPC-157 approved?
No. BPC-157 is not an approved drug and remains a research compound.
[ COMPOUND.PROFILE ]

What Is BPC-157?

BPC-157, formally known as Body Protection Compound-157, is a synthetic pentadecapeptide consisting of 15 amino acids with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is derived from a protective protein found in human gastric juice, known as BPC, which plays a fundamental role in maintaining and repairing the gastrointestinal tract. First isolated and characterized by researchers at the University of Zagreb in the early 1990s, BPC-157 has since become one of the most...

[ EVIDENCE.SUMMARY ]

Evidence Summary

Preclinical-promising · Clinically unproven

BPC-157 is a research compound with promising biological signals but limited human validation. Most claims exceed current clinical evidence.

Evidence Breakdown

Domain Evidence Level
Tissue Healing Limited
Gastric Cytoprotection Limited
Anti-Inflammatory Action Limited
Neuroprotective Properties Limited
Human clinical evidence Limited
Safety data Insufficient
Deep Research Score 2.5 / 5 See full review

Editorial Position

BPC-157 is best understood as a compound with emerging clinical evidence that has not yet reached definitive conclusions. Many online claims exceed the strength of available human evidence, and safety data remains incomplete. Any consideration of this compound should involve careful evaluation of individual context and medical guidance.

Regulatory Status Snapshot

  • Not approved as a therapeutic drug by major regulators
  • Safety profile not established in large human populations

Need help interpreting this evidence for your situation?

Talk to a Specialist
[ STUDIED.FOR ]

What Has BPC-157 Been Studied For?

Research areas where BPC-157 has been investigated in published studies

  • Tissue Healing BPC-157 has been studied in animal models of tissue healing. These findings have not been confirmed in controlled human trials.
  • Gastric Cytoprotection BPC-157 has been studied in animal models of gastric cytoprotection. These findings have not been confirmed in controlled human trials.
  • Anti-Inflammatory Action BPC-157 has been studied in animal models of anti-inflammatory action. These findings have not been confirmed in controlled human trials.
  • Neuroprotective Properties BPC-157 has been studied in animal models of neuroprotective properties. These findings have not been confirmed in controlled human trials.
[ MECHANISM ]

How Does BPC-157 Work?

These mechanisms have been observed in preclinical models. They are plausible but have not been linked to proven clinical outcomes in humans.

  1. 01 Receptor interaction
  2. 02 Intracellular signaling
  3. 03 Downstream biological effect
  4. 04 Angiogenesis & Tissue Repair
NEXT STEP

Not sure if BPC-157 is right for you?

A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about BPC-157.

Speak with a Specialist
[ COMMUNITY.FEEDBACK ]

Community Reports (Anecdotal)

Experiences shared here are self-reported and do not represent clinical evidence.

Rate BPC-157

Your privacy is protected. Share anonymously if you prefer.
Your Rating
[ ADMINISTRATION ]

How Is BPC-157 Administered?

BPC-157 is available via Subcutaneous injection, auto-injector pen, oral capsule. Appropriate use and protocol should be determined by a qualified specialist.

[ REFERENCE.DATA ]

What Are the Specifications of BPC-157?

Format Lyophilized Powder
Amount 5mg per vial
Purity >99.5%
Purity Method HPLC (High-Performance Liquid Chromatography)
Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular Weight 1419.53 g/mol
Storage Store lyophilized powder at -20°C. Reconstituted solution at 2-8°C. Protect from light.
Appearance White to off-white lyophilized powder
[ EXPLORE ]

What Conditions Has BPC-157 Been Linked To?

Have Questions About BPC-157?

Published studies on BPC-157 can be found on PubMed and other peer-reviewed databases. Our references section below lists key citations.

BPC-157 is available as a research compound in Thailand. Consult a qualified specialist to discuss whether it is appropriate for your needs.

A qualified specialist experienced with peptide therapies can help you understand the current evidence and determine suitability.

[ PUBLISHED.RESEARCH ]

What Does the Published Research Say?

  1. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review

    Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM. HSS Journal (2025).

  2. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain

    Lee E, Padgett B. Alternative Therapies in Health and Medicine, 27(4) (2021).

  3. Multifunctionality and Possible Medical Application of the BPC 157 Peptide: Literature and Patent Review

    Jozwiak M, Bauer M, Kamysz W, Kleczkowska P. Pharmaceuticals, 18(2) (2025).

Ready to discuss BPC-157 with a specialist?

Get evidence-based guidance tailored to your health goals and medical context.

Book a Consultation Free initial consultation. No obligation.
EDITORIAL REVIEW

Reviewed by the Peptide Science Thailand Editorial Team.

Last reviewed: March 1, 2026

Share Your Experience

Not Medical Advice

The information provided on this website, including compound profiles, mechanism of action explanations, research summaries, dosage information, and educational content, is for informational and educational purposes only. This information does not constitute medical advice, diagnosis, or treatment recommendations. No content on this website should be interpreted as a substitute for professional medical advice, diagnosis, or treatment.

Medical Supervision Essential

All peptide compounds discussed on this website should only be used under the supervision of a qualified specialist. A healthcare provider should evaluate individual health status, medical history, current medications, and specific health objectives before any peptide use. Self-administration of research peptides without medical supervision is strongly discouraged and may pose significant health risks.

Individual Variation

Individual responses to peptide compounds vary significantly based on genetics, age, body composition, existing health conditions, concurrent medications, and other biological factors. Dosage information provided on this website represents general research ranges and should not be used for self-dosing. A qualified specialist should determine the appropriate compound, dosage, administration route, cycle duration, and monitoring protocol based on individual health assessment.

Liability Limitation

Peptide Science Thailand assumes no liability for the misuse of information provided on this website. The content is provided for educational purposes only. Users are responsible for ensuring they work with qualified healthcare providers before using any peptide compounds discussed herein. Peptide Science Thailand is not responsible for adverse effects resulting from use without proper medical oversight.

Regulatory Status

Many peptides discussed here have not been evaluated or approved by the FDA for therapeutic use unless specifically noted (e.g., Tesamorelin, PT-141). The regulatory status of peptide compounds varies by jurisdiction. Some compounds discussed on this website are approved medications in other countries (e.g., Semax and Selank in Russia). This content is for informational and educational purposes only. Users are responsible for understanding and complying with all applicable laws and regulations in their jurisdiction.